How two forms of elinzanetant are processed in healthy women
Part of Women’s health & pregnancy clinical trials.
This study looks at how the body handles two different forms of a drug called elinzanetant in healthy women. It helps doctors understand the drug's effects and may guide future treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a woman aged 18 to 65
- Be in good overall health
- Weigh at least 50 kg (about 110 lbs) and have a BMI between 18 and 32
- Agree to use effective birth control if you could become pregnant
- Not have taken certain medications or participated in another trial recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women in Canada who are starting fezolinetant, a new medication for hot flashes during menopause. Researchers will track how well it works and how you feel while using it in your regular doctor's care.
This trial checks how a new experimental drug (called Navlimetostat) interacts with other medicines and how food affects it. Healthy women participate to help researchers find the right dose and safety, which could later help people with cancer.
This study tracks how women use elinzanetant for menopause symptoms and how well it works for them. It does not test a new drug; it simply observes women who are already taking it, which helps gather real-world information about its effectiveness and side effects.
This study tests a medication called fezolinetant to see if it helps with hot flashes and also looks at its effects on blood vessels and the brain. It is for women who are going through menopause and having frequent moderate to severe hot flashes.
This trial tests an investigational medication, BZ371A, to see if it can help women with Female Sexual Arousal Disorder (FSAD), a condition where they have trouble getting or keeping physical signs of arousal like lubrication and warmth. The study aims to find out if BZ371A is safe, effective, and well-tolerated.
This study looks at how hot flashes in midlife women might be connected to heart disease risk. Researchers want to see if managing hot flashes can improve heart health.
Hear when a new Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.